A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria

Abroad (travel likely)RecruitingPHASE2

Conditions

Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy · Severe Proteinuria Due to Idiopathic Membranous Nephropathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Aarhus Universitetshospital, Aarhus, Denmark
Contact: Study coordinator (Henrik Birn, Professor) · henrbirn@rm.dk · +45 40460271

Study leads

Henrik Birn, Professor
Principal Investigator
Aarhus University Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.

Fluid Overload · Glomerulosclerosis, Focal Segmental · Edema

Abroad (travel likely)Recruiting

Ann Arbor, United States

SLIT ABS: Study on Patients With Autoimmune Podocytopathy

Nephrotic Syndrome With Edema (Diagnosis) · Minimal Change Nephrotic Syndrome · Focal Segmental Glomerulosclerosis (FSGS)

Abroad (travel likely)Recruiting

Rochester, United States · München, Germany